Production (Stage)
Organogenesis Holdings Inc.
ORGO
$3.03
$0.155.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -373.17% | -82.59% | -156.77% | -264.66% | -56.86% |
| Total Depreciation and Amortization | 12.48% | 10.80% | -20.78% | -19.59% | -20.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 64.43% | 57.64% | 138.87% | 101.09% | 23.64% |
| Change in Net Operating Assets | -81.46% | -170.51% | -67.64% | 27.15% | 32.65% |
| Cash from Operations | -82.83% | -54.04% | -50.59% | 30.33% | 40.61% |
| Capital Expenditure | 39.89% | 58.82% | 68.47% | 62.89% | 45.31% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 39.89% | 58.82% | 68.47% | 62.89% | 45.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1,022.50% | -1,207.64% | -29.05% | -71.04% | -74.49% |
| Issuance of Common Stock | 503.87% | 124,700.00% | -- | 546.43% | -89.83% |
| Repurchase of Common Stock | -2,266.32% | -7,904.50% | -252.55% | -251.80% | -152.18% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 509.90% | 602.03% | -39.01% | -82.41% | -157.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 30,807.25% | 2,935.59% | 57.60% | 104.13% | 99.64% |